A3907, a clinical systemic apical bile acid transporter inhibitor, reprograms fatty acid utilization towards omega-6 metabolism promoting reduced inflammation, fibrosis, and steatosis
HEPATOLOGY（2023）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要